Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures
暂无分享,去创建一个
Sriram Subramaniam | Mario J. Borgnia | William C. Olson | Ian A. Wilson | Alberto Bartesaghi | A. Bartesaghi | M. Borgnia | S. Subramaniam | John P. Moore | I. Wilson | D. Shi | J. Milne | R. Sanders | R. Depetris | R. Pejchal | P. Klasse | A. Marozsan | A. Harris | W. Olson | Rogier W. Sanders | Andre J. Marozsan | Robert Pejchal | Dan Shi | Audray Harris | Rafael Depetris | Per Johan Klasse | Jacqueline L. S. Milne | Haifeng He | Yun (Kenneth) Kang | Yun Kenneth Kang | Haifeng He | Audray K. Harris
[1] Bette Korber,et al. Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.
[2] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[3] Q. Sattentau,et al. Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals , 2010, PloS one.
[4] David C Montefiori,et al. The role of antibodies in HIV vaccines. , 2010, Annual review of immunology.
[5] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[6] J. Binley,et al. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. , 2009, Vaccine.
[7] L. Xing,et al. Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding , 2011, Proceedings of the National Academy of Sciences.
[8] H. Garoff,et al. Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure , 2010, Proceedings of the National Academy of Sciences.
[9] William C. Olson,et al. Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.
[10] T L Hoffman,et al. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] D R Burton,et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. , 1994, Science.
[12] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[13] John P. Moore,et al. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? , 2012, AIDS research and human retroviruses.
[14] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[15] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[16] John P. Moore,et al. Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[17] J. Sodroski,et al. Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers , 2001, Journal of Virology.
[18] D. Burton,et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.
[19] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[20] J. Binley,et al. A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure , 2000, Journal of Virology.
[21] J. Sodroski,et al. Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3d , 2004, Journal of Virology.
[22] D. Burton,et al. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. , 2010, Current opinion in immunology.
[23] A. Bartesaghi,et al. Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure , 2010, PLoS pathogens.
[24] John P. Moore,et al. Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A. , 2006, AIDS research and human retroviruses.
[25] G Sapiro,et al. Classification and 3D averaging with missing wedge correction in biological electron tomography. , 2008, Journal of structural biology.
[26] D. Burton,et al. GP120: target for neutralizing HIV-1 antibodies. , 2006, Annual review of immunology.
[27] A. Bartesaghi,et al. Membrane protein structure determination using cryo-electron tomography and 3D image averaging. , 2009, Current opinion in structural biology.
[28] S. A. Gallo,et al. The HIV Env-mediated fusion reaction. , 2003, Biochimica et biophysica acta.
[29] John P. Moore,et al. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120. , 2007, Virology.